University of Wisconsin - Aug. 18, 2010

$117.00
Regarding manufacture of PET drug 13N NH3, a USP monograph drug which is used for diagnostic purposes and not under IND or RDRC review: No formal process validation or verification (min. three consecutive batches) has been performed.